1,432 results on '"Hong, Theodore S."'
Search Results
52. Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation
53. Impact of Postoperative Complication and Completion of Multimodality Therapy on Survival in Patients Undergoing Gastrectomy for Advanced Gastric Cancer
54. Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas
55. Clinical staging in pancreatic adenocarcinoma underestimates extent of disease
56. Patient Survival with ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer
57. Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)
58. Supplementary Figure S7 from Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer
59. Supplementary Table S2 from Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer
60. Data from Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer
61. DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair
62. Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer
63. Elucidating the Benefit of Radiation Therapy in GI Cancers: Rethinking Trial End Points and Patient Selection
64. Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma
65. Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation
66. Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma
67. Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes
68. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma
69. Sexual Function, Quality of Life, and Mood After Radiation Therapy in Patients with Anal Cancer
70. Clinical impact of PET/MR in treated colorectal cancer patients
71. Role of Radiation Therapy for Intrahepatic Cholangiocarcinoma
72. Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study
73. Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival
74. Inter-patient variations of radiation-induced normal-tissue changes in Gd-EOB-DTPA-enhanced hepatic MRI scans during fractionated proton therapy
75. Quasimesenchymal phenotype predicts systemic metastasis in pancreatic ductal adenocarcinoma
76. The American Brachytherapy Society consensus statement on intraoperative radiation therapy
77. Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal Cancer
78. To Radiate, Not to Radiate, or to Dose-Escalate?
79. Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis
80. ASO Visual Abstract: Neoadjuvant versus Postoperative Chemoradiotherapy Is Associated with Improved Survival in Patients with Resectable Gastric and Gastroesophageal Cancer
81. Elucidating the Benefit of Radiation Therapy in GI Cancers: Rethinking Trial End Points and Patient Selection.
82. SBRT with ipilimumab and nivolumab to metastatic MSS colorectal and pancreatic cancer: A pooled analysis of four prospective phase II trials.
83. Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy
84. The Multidisciplinary Management of Early-Stage Thoracic Esophageal Cancer
85. Radiation Therapy for Intrahepatic and Hilar Cholangiocarcinoma: Clinical Data
86. Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer
87. Clinical needs assessment for sexual health among cancer patients receiving pelvic radiation: Implications for development of a radiation oncology sexual health clinic
88. Pilot study on the impact of F18-labeled thymidine PET/CT on gross tumor volume identification and definition for pancreatic cancer
89. Patterns of Care for Stage II-III Rectosigmoid Cancers in the United States, 2004-2015
90. A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types
91. Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma?
92. Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer
93. Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer
94. Toward Personalized Radiation Therapy of Liver Metastasis: Importance of Serial Blood Biomarkers
95. Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target
96. Therapy-associated remodeling of pancreatic cancer revealed by single-cell spatial transcriptomics and optimal transport analysis
97. A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable colorectal cancer.
98. MRI-Based Tumor Necrosis Depiction in Pancreatic Ductal Adenocarcinoma: Can It Predict Tumor Aggressiveness?
99. Supplementary Table S2 from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer
100. Data from Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.